Inventor · disambiguated record
Yang Liu
Also filed as: LIU YANG · LIU YANG JACK
111 granted patents·116 pending applications·164 citations·filing 2001–2025
99Inventor score
Top patents by PatentIndex Score
227 records- 0195US10618960B2Chimeric and humanized anti-human CTLA4 monoclonal antibodies and uses thereofONCOIMMUNE INC·Filed 2016·Granted Apr 14, 2020·12 cites·14 claims
- 0293US12227557B2CD80 and CD86 binding protein compositions and uses thereofONCOC4 INC·Filed 2022·Granted Feb 18, 2025·2 cites·20 claims
- 0391US8461134B2Boron-containing small moleculesHERNANDEZ VINCENT S·Filed 2010·Granted Jun 11, 2013·24 cites·25 claims
- 0489US9777073B2Construction and application of bispecific antibody EpCAM×CD3WUHAN YZY BIOPHARMA CO LTD·Filed 2015·Granted Oct 3, 2017·8 cites·2 claims
- 0588US12145873B1Preparation method for modified cathode of MEC-AD system and application of system with high efficiency and low energy consumptionJIANGSU ACAD AGRICULTURAL SCI·Filed 2024·Granted Nov 19, 2024·1 cites·10 claims
- 0687US2025304603A1Oxaborole esters and uses thereofANACOR PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0786US11261233B2CD80 and CD86 binding protein compositions and uses thereofONCOC4 INC·Filed 2017·Granted Mar 1, 2022·6 cites·19 claims
- 0885US12122787B2Fused pyridone compound, and preparation method therefor and use thereofSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2023·Granted Oct 22, 2024·1 cites·13 claims
- 0985US10369197B2Use of CD24 for lowering low-density lipoprotein cholesterol levelsONCOLMMUNE INC·Filed 2016·Granted Aug 6, 2019·3 cites·21 claims
- 1084US8642029B2Transiently buffered Lactobacillus preparations and use thereofWANG JUN·Filed 2009·Granted Feb 4, 2014·6 cites·10 claims
- 1184US8329447B2Strain of Lactobacillus crispatusLIU YANG·Filed 2009·Granted Dec 11, 2012·4 cites·11 claims
- 1283US11292000B2Devices and methods for separating circulating tumor cells from biological samplesUNIV GEORGIA·Filed 2019·Granted Apr 5, 2022·2 cites·20 claims
- 1382US10793617B2Methods of use of soluble CD24 for therapy of rheumatoid arthritisONCOIMMUNE INC·Filed 2018·Granted Oct 6, 2020·1 cites·14 claims
- 1482US10156479B2Spatial-domain low-coherence quantitative phase microscopyUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2014·Granted Dec 18, 2018·5 cites·15 claims
- 1582US9611309B2Methods of use of soluble CD24 for therapy of rheumatoid arthritisONCOIMMUNE INC·Filed 2014·Granted Apr 4, 2017·2 cites·17 claims
- 1681US8895022B2Methods of use of soluble CD24 for therapy of rheumatoid arthritisONCOIMMUNE INC·Filed 2013·Granted Nov 25, 2014·2 cites·9 claims
- 1781US8163281B2Treatment of drug-related side effect and tissue damage by targeting the CD24-HMGB1-Siglec10 axisLIU YANG·Filed 2010·Granted Apr 24, 2012·4 cites·3 claims
- 1881US7744894B2Method of treating multiple sclerosis and related t-cell initiated tissue destruction by administering HSA/CD24LIU YANG·Filed 2005·Granted Jun 29, 2010·4 cites·6 claims
- 1981US7504554B2Animal model for identifying agents that inhibit or enhance CTLA4 signalingUNIV OHIO STATE RES FOUND·Filed 2007·Granted Mar 17, 2009·9 cites·4 claims
- 2081US2023132298A1Oxaborole esters and uses thereofANACOR PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2180US11026995B2Use of CD24 for lowering low-density lipoprotein cholesterol levelsONCOLMMUNE INC·Filed 2019·Granted Jun 8, 2021·1 cites·16 claims
- 2279US12473362B2Chimeric and humanized anti-human CTLA4 monoclonal antibodies and uses thereofONCOC4 INC·Filed 2023·Granted Nov 18, 2025·0 cites·12 claims
- 2379US11401295B2Cyclic dinucleotide compound and uses thereofSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2019·Granted Aug 2, 2022·2 cites·20 claims
- 2478US11795265B2Macromonomeric stabilizer, preparation method thereof, and method for preparing polymeric polyolWANHUA CHEMICAL GROUP CO LTD·Filed 2018·Granted Oct 24, 2023·1 cites·18 claims
- 2578US10537555B2Complex of angiotensin receptor antagonist and neutral endopeptidase inhibitorCHENGDU EASTON BIOPHARMACEUTICALS CO LTD·Filed 2016·Granted Jan 21, 2020·2 cites·19 claims
- 2678US9518921B2Silica nanoparticles with aggregation induced emission characteristics as fluorescent bioprobe for intracellular imaging and protein carrierUNIV HONG KONG SCIENCE & TECH·Filed 2012·Granted Dec 13, 2016·3 cites·30 claims
- 2778US2024230634A9Devices, kits, and methods for label-free focusing and/or separation of sub-micron particlesUNIV GEORGIA·Filed 2023·Application pending·0 cites
- 2877US10556964B2Bispecific antibody-mediated cancer therapy with cytokine-induced killer cellWUHAN YZY BIOPHARMA CO LTD·Filed 2014·Granted Feb 11, 2020·3 cites·9 claims
- 2977US8808697B2Methods of use of soluble CD24 for therapy of rheumatoid arthritisZHENG XINCHENG·Filed 2011·Granted Aug 19, 2014·6 cites·6 claims
- 3076US12441780B2CD80 and CD86 binding protein compositions and uses thereofONCOC4 INC·Filed 2022·Granted Oct 14, 2025·0 cites·17 claims
- 3176US10562921B2Oxaborole esters and uses thereofANACOR PHARMACEUTICALS INC·Filed 2017·Granted Feb 18, 2020·1 cites·22 claims
- 3275US9744270B2Nanocrystalline cellulose hydrogels for inhibition of bacterial adhesionUNIV ALBERTA·Filed 2014·Granted Aug 29, 2017·3 cites·18 claims
- 3375US7161058B2Animal model for identifying agents that inhibit or enhance CTLA4 signalingUNIV OHIO STATE RES FOUND·Filed 2005·Granted Jan 9, 2007·5 cites·4 claims
- 3474US10882872B2Oxaborole esters and uses thereofANACOR PHARMACEUTICALS INC·Filed 2019·Granted Jan 5, 2021·0 cites·13 claims
- 3574US2025043003A1Mutant anti-ctla-4 antibodies with improved immunotherapeutic effect but attenuated adverse effectsONCOC4 INC·Filed 2024·Application pending·0 cites
- 3672US10961261B2Oxaborole analogs and uses thereofANACOR PHARMACEUTICALS INC·Filed 2018·Granted Mar 30, 2021·1 cites·20 claims
- 3772US2020399345A1Methods of use of soluble cd24 for therapy of rheumatoid arthritisONCOIMMUNE INC·Filed 2020·Application pending·0 cites
- 3871US11578087B2Oxaborole esters and uses thereofANACOR PHARMACEUTICALS INC·Filed 2020·Granted Feb 14, 2023·0 cites·11 claims
- 3971USD885232SFinger ringLIU YANG JACK·Filed 2019·Granted May 26, 2020·11 cites·1 claims
- 4071US9255107B2Heteroaryl alkyne compound and use thereofNANJING SANHOME PHARMACEUTICAL CO LTD·Filed 2013·Granted Feb 9, 2016·1 cites·18 claims
- 4171US2024076405A1Expression vectors for immunoglobulins and applications thereofCANTON BIOLOGICS CO LTD·Filed 2023·Application pending·0 cites
- 4271US2021161991A1Uses of hypoxia-inducible factor inhibitorsONCOIMMUNE INC·Filed 2020·Application pending·0 cites
- 4370US12351496B2Microbial assisted phosphorous recovery under anaerobic conditionUNIV ALBERTA·Filed 2022·Granted Jul 8, 2025·0 cites·11 claims
- 4470US8158596B2Materials and methods for FOXP3 tumor suppressionLIU YANG·Filed 2008·Granted Apr 17, 2012·2 cites·9 claims
- 4569US12043830B2Application of prokaryotic Argonaute protein with only RNA target cleavage activity in RNA editingUNIV HUBEI·Filed 2023·Granted Jul 23, 2024·0 cites·3 claims
- 4669US2020147167A1Uses of hypoxia-inducible factor inhibitorsONCOIMMUNE INC·Filed 2020·Application pending·0 cites
- 4768US12486300B2Mithramycin oxime derivatives having increased selectivity and anti-cancer activityUNIV KENTUCKY RES FOUND·Filed 2022·Granted Dec 2, 2025·0 cites·12 claims
- 4868US11691992B2Oxaborole analogs and uses thereofANACOR PHARMACEUTICALS INC·Filed 2021·Granted Jul 4, 2023·0 cites·20 claims
- 4968US11661417B2Low-molecular mass organic gellant and preparation method and use thereofUNIV TIANJIN·Filed 2022·Granted May 30, 2023·0 cites·6 claims
- 5068US10016490B2Multiple-enzyme nanocomplexesLU YUNFENG·Filed 2012·Granted Jul 10, 2018·1 cites·12 claims
Showing the top 50 of 227 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yang Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →